Christopher So

Christopher So is an Associate Professor in the Department of Pharmaceutical Sciences at Roseman University of Health Sciences. His research focuses on G-protein coupled receptor kinases (GRKs) and their roles in human cancer, stress responses, and drug resistance mechanisms. He utilizes Caenorhabditis elegans as a model organism and employs bioinformatic and cellular approaches to study novel signaling pathways.

• Education: Bachelor of Science in Toxicology and Doctor of Philosophy in Pharmacology from the University of Toronto
• Teaching: Gastrointestinal, cardiovascular, and renal systems, as well as neuropharmacology
• Affiliations: American Association of Colleges of Pharmacy, American Association for Cancer Research, American Heart Association

Dr. So's research investigates GRKs in both cancer progression and cellular stress adaptation. His work explores how these kinases influence chemotherapeutic resistance and interact with signaling components like NADPH oxidase 4. Publications highlight GRK2 and GRK5 in oxidative stress survival, cisplatin reactions, and nucleolar stress responses.

Scientific Awards:

• Research Fellowship from the Heart and Stroke Foundation of Canada